top of page

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Orblicef 2.5gm Injection

Orblicef 2.5gm Injection

Manufacturer/Marketed By : ORCHID PHARMA LTD

$16.87 $13.84

Orblicef 2.5gm Injection is a combination of two medicines: Cefepime and Enmetazobactam. Cefepime is an antibiotic from the cephalosporin group, and Enmetazobactam helps make the antibiotic more effective by blocking...

CEFEPIME,ENMETAZOBACTAM

Active Pharmaceutical Ingredient

Orblicef 2.5gm Injection

SKU ORBLICEF-2-5GM-INJECTION
Original price

$16.87

Sale price

$13.84

Orblicef 2.5gm Injection is a combination of two medicines: Cefepime and Enmetazobactam. Cefepime is an antibiotic from the cephalosporin group, and Enmetazobactam helps make the antibiotic more effective by blocking certain enzymes that bacteria use to protect themselves. This medicine belongs to a group of Medications called broad-spectrum antibiotics and is used to treat serious infections like complicated urinary tract infections (cUTIs), lung infections such as hospital-acquired pneumonia, and other severe infections caused by resistant bacteria. Orblicef Injection is usually given in hospitals by a healthcare professional through an injection. Like all medicines, it may cause some side effects such as nausea, diarrhea, headache, or pain at the injection site. Orblicef 2.5gm Injection should be used exactly as directed by the doctor. It may not be safe for people who have kidney problems unless the dose is adjusted. It should not be used by anyone who is allergic to cephalosporins, penicillins, or similar antibiotics. Always tell your doctor about any health problems or other medicines you are taking before starting this treatment.

Active Pharmaceutical Ingredient

CEFEPIME,ENMETAZOBACTAM

Uses

• Complicated urinary tract infections (cUTIs), including pyelonephritis, in adults.
• Hospital-acquired pneumonia (HAP), including ventilator-associated pneumonia (VAP).
• Bacteraemia associated with, or suspected to be associated with, cUTIs or HAP.

Benefits

Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.

Side Effects

Like all medicines, Orblicef 2.5gm Injection may cause side effects, though not everyone gets them. Most are mild and manageable, but some may need medical attention.

Most Common Side Effects

• Severe allergic reactions (e.g., swelling of face, lips, or throat; difficulty breathing)
• Seizures or confusion, especially in patients with kidney problems
• Clostridium difficile-associated diarrhea (persistent or severe)
• Low white blood cell count (may increase risk of infections)
• Kidney problems (changes in urine output or swelling)

Common Side Effects

• Nausea or vomiting
• Diarrhea
• Headache
• Rash or itching
• Redness or pain at the injection site
• Increased liver enzymes (usually mild and temporary)

How To Use

Orblicef 2.5gm Injection is available as an intravenous injection and is administered by a healthcare professional in a hospital setting. The recommended dose for adults is 2g/0.5g every 8 hours, infused over 2 hours. It is not taken with food and should never be self-administered. Dosage may vary based on kidney function and severity of infection. Always follow the doctor’s instructions closely.

Safety Advice

• Pregnancy: There is limited information on the use of this medicine during pregnancy. It should only be used if clearly needed and prescribed by a healthcare provider.
• Breast Feeding: Small amounts of the medication may pass into breast milk. A doctor will assess the benefits and potential risks before recommending use during breastfeeding.
• Lungs: Patients with severe respiratory conditions should inform their doctor before starting this medication, as infections and side effects may impact breathing.
• Liver: No major dose adjustments are generally required in patients with liver issues, but monitoring is advised.
• Alcohol: It is advised to avoid alcohol during treatment, as it may increase the risk of side effects like dizziness or stomach upset
• Driving: This medicine may cause confusion, dizziness, or seizures. Avoid driving until you know how it affects you.

Disclaimer

Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.

Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.

All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.

Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.

bottom of page